PreDEA Study, Prevention in Emergency / Acceptance Departments: the Case of Hepatic Steatosis

Launched by UNIVERSITY OF L'AQUILA · Jun 24, 2022

Keywords

ClinConnect Summary

The PreDEA Study is a clinical trial focused on understanding and improving the prevention and management of a common liver condition known as hepatic steatosis, or fatty liver disease, in patients who visit the Emergency Department (ED). The goal of the study is to find out how many people have this condition and to explore how the ED can play a role in screening and raising awareness about it. This information will help shape future research to enhance health care practices related to chronic inflammatory diseases.

To participate in this study, you need to be at least 18 years old and have been admitted to the Emergency Department with less severe conditions (coded as "white" or "green"). Unfortunately, if you are under 18 or have more serious conditions (coded as "yellow" or "red"), you won't be eligible. If you join the study, you can expect to provide information about your health, which will help researchers better understand how to address fatty liver disease in the community. The study is currently looking for participants, and your involvement could lead to important advancements in health care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients over 18
• • Patients admitted to Emergency department in white or green code
• Exclusion Criteria:
• • Patients under 18
• • Patients admitted to Emergency department in yellow or red code